ONCO vs TECH · P/E 0.0, rev $2.5M vs P/E 65, rev $1.22B
Onconetix Inc (ONCO) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Onconetix Inc (ONCO) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ONCO revenue for 2024-12-31 was $2.5M. Net income was -$58.7M. Revenue was up 4217.3% from 2023-12-31 to 2024-12-31. ONCO currently screens at market cap $3.7M and trailing P/E 0.0.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ONCO currently screens at market cap $3.7M and trailing P/E 0.0. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ONCO and TECH stock pages for the full models.
Not investment advice.